DEEPSEEK
Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts
Investors are re-evaluating large pharmaceutical companies due to innovations in GLP-1, AI-driven drug discovery, and changing healthcare consumption patterns, according to VanEck.
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025
AI is transforming the pharmaceutical and biotech industries, driving innovation and reshaping investment landscapes according to VanEck’s BBH ETF analysis.
Lilly Unveils Groundbreaking AI Factory for Drug Discovery with NVIDIA's DGX SuperPOD
Lilly has launched the largest AI factory in the pharmaceutical sector, leveraging NVIDIA's DGX SuperPOD to revolutionize drug discovery and personalized medicine.
IQVIA and NVIDIA Collaborate to Enhance Clinical Trials with AI Innovations
IQVIA and NVIDIA introduce AI orchestrator agents to streamline clinical trials and drug commercialization, aiming to accelerate the delivery of therapies to patients.
NVIDIA Launches BioNeMo Framework to Revolutionize Drug Discovery and Molecular Design
NVIDIA unveils the open-source BioNeMo Framework, aiming to transform the biopharma industry by accelerating drug discovery and molecular design through advanced AI and supercomputing.
NVIDIA's NIM Agent Blueprint Transforms Drug Discovery with AI-Driven Virtual Screening
NVIDIA's NIM Agent Blueprint leverages generative AI for faster, cost-effective drug discovery, enhancing hit-to-lead transitions.
CVS Pharmacy Files for NFT and Metaverse Trademarks Registration
Healthcare giant CVS Pharmacy has filed for a new trademark with the intention of offering Non-Fungible Token (NFT) related products.
Blockchain Can Make Patients Profit From Personal Health Data
Jim Nasr, a healthtech expert who is the Vice President of Technology and Innovation at Certara, has forecasted that blockchain could assist patients own, share, and monetize their own health data.
